Full Press Release Details
Accessibility: Skip TopNav
Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
August 29, 2018 07:00 ET
Summit Therapeutics plc
Summit Therapeutics plc
Summit Therapeutics plc
("Summit", or the "Company")
Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
Oxford, UK, and Cambridge, MA, US, 29 August 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that Mr Glyn Edwards, Chief Executive Officer, will present on the Company's plans to advance its new mechanism antibiotic pipeline at the Rodman & Renshaw 20th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, 6 September 2018 at 11:15am EDT in New York City.
A live webcast of the presentation will be available in the Investors section of the Company's website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation.
About Summit Therapeutics
For more information, please contact:
| Summit | ||
| Glyn Edwards / Richard Pye (UK office) | Tel: | 44 (0)1235 443 951 |
| Erik Ostrowski / Michelle Avery (US office) | +1 617 225 4455 | |
| Cairn Financial Advisers LLP (Nominated Adviser) | Tel: | +44 (0)20 7213 0880 |
| Liam Murray / Tony Rawlinson | ||
| N+1 Singer (Joint Broker) | Tel: | +44 (0)20 7496 3000 |
| Aubrey Powell / Jen Boorer | ||
| Panmure Gordon (Joint Broker) | Tel: | +44 (0)20 7886 2500 |
| Freddy Crossley, Corporate Finance | ||
| James Stearns, Corporate Broking | ||
| MSL Group (US) | Tel: | +1 617 684 6557 |
| Jon Siegal | Jon.siegal@mslgroup.com | |
| Consilium Strategic Communications (UK) | Tel: | +44 (0)20 3709 5700 |
| Mary-Jane Elliott / Jessica Hodgson | summit@consilium-comms.com | |
| / Lindsey Neville |